Dendritic cell recruitment and activation in autoimmunity

Area of Science:

• Immunology
• Autoimmunity
• Cell Biology

Background:

• Dendritic cells (DCs) are key antigen-presenting cells that initiate immune responses.
• DCs have two main subsets: conventional DCs (cDCs) for antigen presentation and plasmacytoid DCs (pDCs) for type I interferon production.
• DC dysfunction is implicated in various autoimmune diseases, but their precise roles are still being defined.

Purpose of the Study:

• To review current literature on DC biology aspects that promote autoimmunity.
• To focus on DC tissue entry, activation, and cytokine production in the context of autoimmune diseases.
• To discuss the role of innate immune receptor signaling in DC activation and subsequent autoimmunity.

Main Methods:

• Literature review of studies on dendritic cell biology and autoimmunity.
• Analysis of mechanisms of DC tissue accumulation and activation.
• Examination of cytokine production by DCs and its impact on immune balance.

Main Results:

• Altered DC functions, including inappropriate activation by tissue-derived signals via Toll-like receptors, contribute to autoimmunity.
• pDCs overproduce type I interferons, a hallmark of conditions like lupus and type 1 diabetes.
• cDCs mature rapidly and secrete Th1/Th17 cytokines, while tissue-derived molecules promote autoantigen spreading, potentially via pDC-derived Granzyme B.

Conclusions:

• DC biology, particularly their activation and cytokine profiles, is critical in maintaining immune homeostasis.
• Dysregulated DC responses to tissue damage signals are central to the pathogenesis of multiple autoimmune diseases.
• Targeting DCs presents a promising therapeutic strategy for human autoimmune conditions.